SCIENTIFIC PROGRAMME

Thursday September 19th

09:00 - 14:00 Registration
14:00 - 15:30 Plenary Session/ Kosovel Hall
CEVF Symposium
Peripheral Arterial Disease - Indicator of Polyvascular Disease
Chairs: Claudio Allegra (Italy), Pavel Poredoš (Slovenia)   6x15 min
  • Relationship between PAD and cerebrovascular disease
    Salvatore Novo (Italy)
  • PAD and risk for coronary artery disease
    Rodica Avram (Romania)
  • Estimation of risk for cardiovascular events in patients with polyvascular disease
    Borut Jug (Slovenia)
  • Diagnostic assesment to patients with polyvascular disease
    Pier Luigi Antignani (Italy)
  • Conservative treatment of patients with polyvascular disease
    Barbara Krevel (Slovenia)
  • Treatment of patients with polyvascular disease: Surgical options
    Arkadiusz Jawien (Poland)
15:30 - 16:30 Parallel Session/ Kosovel Hall

Young IUA Symposium
IUA Position Statements
Chairs: Rok Luciano Perme (Slovenia), TBA   4x15 min

  • IUA position statement on no-option CLTI
    Michal Juszynski (Poland)
  • Vaccines Directed Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
    Andrej Juretič (Slovenia)
  • IUA position statement on perioperative drug and hemostasis management in vascular surgery
    Joao Rocha Neves (Portugal)
  • IUA consensus document on vascular compression syndromes 
    Mario D’Oria (Italy)
15:30 - 16:30 Parallel Session/ E1,2 Hall

Microcirculation

Chairs: Patrick Carpentier (France), Mateja Kaja Ježovnik (USA)   4x15 min
  • The link between macro- and microcirculation and its deterioration 
    Mateja Kaja Ježovnik (USA)
  • Involvement of microcirculation in the development of CLTI 
    Pavel Poredoš (Slovenia)
  • Diagnostic procedures for detecting microangiopathy 
    Patrick Carpentier (France)
  • Management of diabetic microangiopathy 
    Pier Luigi Antignani (Italy)
16:30 - 17:00 Coffee Break and Poster Viewing

17:00 - 18:00 Presidential Lectures/  Kosovel Hall

Chair: Aleš Blinc (Slovenia)  3x20 min

  • How noninvasive investigations have modified our therapeutical approach
    Pier Luigi Antignani, President of the CEVF and Past President of the IUA
  • Interrelationship between arterial atherosclerosis and venous disease
    Pavel Poredoš, IUA Vice President of the Multinational Chapter
  • Carotid atherosclerosis is predictive of coronary atherosclerosis and events
    Salvatore Novo, Past President of the IUA and CEVF

18:00 - 19:00 Parallel Session/  Kosovel Hall


Anticoagulant Therapy and Venous Thromboembolism

Chairs: Gregor Tratar (Slovenia), TBA   3x20 min
  • Treatment of upper extremity DVT with DOACs
    Maria Cristina Vedovati (Italy)
  • Extended treatment of venous thromboembolism
    Paolo Prandoni (Italy)
  •  Cancer-associated thromboembolism and thrombocytopenia
    Gregor Tratar (Slovenia)

18:00 - 19:00 Parallel Session E1,2 Hall

VAS Symposium
Buerger’s Disease Pathophysiology: From Hypotheses to Evidence Synthesis
Chairs: Pavel Poredoš (Slovenia), Bahar Fazeli (Iran)   5x12 min
  • Is Buerger’s Disease a variant of atherosclerosis? 
    Takehisa Iwai (Japan)
  • Is Buerger’s Disease a rickettsial infection?
    Pier Luigi Antignani (Italy)
  • Smoking and Buerger’s Disease
    Andrzej Szuba (Poland)
  • Inflammation and immune  dysregulation in Buerger’s Disease  
    Bahar Fazeli (Iran)
  • International Delphi consensus on diagnostic criteria for Buerger’s disease 
    Aaron Liew (Ireland)

19:00 - 19:20 Congress Opening  

19:30 -  21:30 Welcome Reception